中策集團(00235.HK)擬折讓約10.45%增發33.97億股 淨籌2.03億港元
格隆匯 11 月 20日丨中策集團(00235.HK)公告,2020年11月20日,公司與認購方訂立認購協議,公司根據認購協議條款及條件將向認購方發行及配發合共33.97億股新股份,每股認購股份的認購價為0.060港元。較11月20日收市價每股0.067港元折讓約10.45%;認購股份相當於發行認購股份擴大後已發行股份約16.67%(假設公司已發行股份數目由認購協議日期起至完成日期止並無任何變動)。
董事經作出一切合理查詢後所知、所悉及所信,於訂立認購協議前,認購方及其最終實益擁有人均為獨立於公司及其關連人士第三方。認購股份將根據一般授權配發及發行。
所得款項淨額將約為2.03億港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.